5-150129883-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002609.4(PDGFRB):​c.1453G>A​(p.Glu485Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0229 in 1,614,120 control chromosomes in the GnomAD database, including 484 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 48 hom., cov: 33)
Exomes 𝑓: 0.023 ( 436 hom. )

Consequence

PDGFRB
NM_002609.4 missense

Scores

3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.05

Publications

19 publications found
Variant links:
Genes affected
PDGFRB (HGNC:8804): (platelet derived growth factor receptor beta) The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017]
PDGFRB Gene-Disease associations (from GenCC):
  • acroosteolysis-keloid-like lesions-premature aging syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • myofibromatosis, infantile, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • basal ganglia calcification, idiopathic, 4
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • bilateral striopallidodentate calcinosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile myofibromatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary progressive mucinous histiocytosis
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025401115).
BP6
Variant 5-150129883-C-T is Benign according to our data. Variant chr5-150129883-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 473402.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0195 (2969/152378) while in subpopulation NFE AF = 0.0281 (1909/68038). AF 95% confidence interval is 0.027. There are 48 homozygotes in GnomAd4. There are 1418 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 2969 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDGFRBNM_002609.4 linkc.1453G>A p.Glu485Lys missense_variant Exon 10 of 23 ENST00000261799.9 NP_002600.1
PDGFRBNM_001355016.2 linkc.1261G>A p.Glu421Lys missense_variant Exon 9 of 22 NP_001341945.1
PDGFRBNM_001355017.2 linkc.970G>A p.Glu324Lys missense_variant Exon 10 of 23 NP_001341946.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDGFRBENST00000261799.9 linkc.1453G>A p.Glu485Lys missense_variant Exon 10 of 23 1 NM_002609.4 ENSP00000261799.4
PDGFRBENST00000520579.5 linkn.*767G>A non_coding_transcript_exon_variant Exon 10 of 23 1 ENSP00000430026.1
PDGFRBENST00000520579.5 linkn.*767G>A 3_prime_UTR_variant Exon 10 of 23 1 ENSP00000430026.1

Frequencies

GnomAD3 genomes
AF:
0.0195
AC:
2968
AN:
152260
Hom.:
48
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00583
Gnomad AMI
AF:
0.0603
Gnomad AMR
AF:
0.0264
Gnomad ASJ
AF:
0.0274
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00890
Gnomad FIN
AF:
0.0138
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0280
Gnomad OTH
AF:
0.0272
GnomAD2 exomes
AF:
0.0195
AC:
4912
AN:
251424
AF XY:
0.0200
show subpopulations
Gnomad AFR exome
AF:
0.00418
Gnomad AMR exome
AF:
0.0172
Gnomad ASJ exome
AF:
0.0293
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0135
Gnomad NFE exome
AF:
0.0285
Gnomad OTH exome
AF:
0.0246
GnomAD4 exome
AF:
0.0232
AC:
33982
AN:
1461742
Hom.:
436
Cov.:
33
AF XY:
0.0229
AC XY:
16657
AN XY:
727182
show subpopulations
African (AFR)
AF:
0.00469
AC:
157
AN:
33478
American (AMR)
AF:
0.0179
AC:
801
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0275
AC:
718
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00897
AC:
774
AN:
86258
European-Finnish (FIN)
AF:
0.0141
AC:
750
AN:
53378
Middle Eastern (MID)
AF:
0.0369
AC:
213
AN:
5768
European-Non Finnish (NFE)
AF:
0.0263
AC:
29235
AN:
1111906
Other (OTH)
AF:
0.0221
AC:
1332
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
1841
3682
5522
7363
9204
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1044
2088
3132
4176
5220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0195
AC:
2969
AN:
152378
Hom.:
48
Cov.:
33
AF XY:
0.0190
AC XY:
1418
AN XY:
74522
show subpopulations
African (AFR)
AF:
0.00582
AC:
242
AN:
41598
American (AMR)
AF:
0.0263
AC:
403
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0274
AC:
95
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00870
AC:
42
AN:
4830
European-Finnish (FIN)
AF:
0.0138
AC:
147
AN:
10630
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0281
AC:
1909
AN:
68038
Other (OTH)
AF:
0.0269
AC:
57
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
154
308
463
617
771
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0254
Hom.:
139
Bravo
AF:
0.0212
TwinsUK
AF:
0.0259
AC:
96
ALSPAC
AF:
0.0223
AC:
86
ESP6500AA
AF:
0.00477
AC:
21
ESP6500EA
AF:
0.0260
AC:
224
ExAC
AF:
0.0187
AC:
2265
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.0341
EpiControl
AF:
0.0347

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Oct 12, 2023
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria.

Myofibromatosis, infantile, 1 Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Myeloproliferative disorder, chronic, with eosinophilia Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Infantile myofibromatosis;C1866182:Acroosteolysis-keloid-like lesions-premature aging syndrome;C3554321:Basal ganglia calcification, idiopathic, 4;C4225270:Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.078
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.86
D
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
1.2
L
PhyloP100
1.0
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.77
N
REVEL
Benign
0.10
Sift
Benign
0.54
T
Sift4G
Benign
0.74
T
Vest4
0.19
ClinPred
0.010
T
GERP RS
3.7
Varity_R
0.22
gMVP
0.38
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41287110; hg19: chr5-149509446; COSMIC: COSV55801773; COSMIC: COSV55801773; API